Skip to main content
Clinical Trials/CTRI/2023/08/056491
CTRI/2023/08/056491Not yet recruitingPhase 2

To assess the efficacy of addition of intravenous levosulpirideto dexamethasone as prophylaxis for PONV in patientsundergoing B/L TKR: a prospective, randomized, doubleblinded, controlled study. - NI

Dr Sunny Rupal0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients scheduled for bilateral knee replacement surgery of ASA grade 1 and 2 , for degenerative joint disease.
  • 2. Patients with APFEL score of at least 1 or more.

Exclusion Criteria

  • ASA III, IV patients with severe illness
  • 2. Patients with history of severe valular heart disease, vascular or conduction abnormalities
  • 3. Known history of allergy to the study drugs
  • 4. Any contraindication to spinal anesthesia or failure of spinal anesthesia necessitating general anesthesia
  • 5. Patients with neurologic or cognitive disorders/ non cooperative patients/ patients with psychosis.
  • 6. Patients with poor glycemic control HBA1c >8.
  • 7. Severe hepatic or renal dysfunction
  • 8. Intake of anti-emetics or steroids within last 24 hours of surgery
  • 9. Patientâ??s refusal

Investigators

Sponsor
Dr Sunny Rupal

Similar Trials

A study comparing two groups of patients... | Clinical Trial